Meeting
2015 Breast Cancer Symposium
Distant recurrence risk with prospective use of the 21-gene assay at a single institution.
Authors
John Mullinax
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
John Mullinax , Danielle Carr , Nora Vera , Weihong Sun , M. Catherine Lee , Susan Hoover , William J. Fulp , Geza Acs , Christine Laronga
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Systemic Therapy, Survivorship, and Health Policy
Track
Systemic Therapy,Local/Regional Therapy,Survivorship and Health Policy
Sub Track
Biology and Biomarkers
Citation
J Clin Oncol 33, 2015 (suppl 28S; abstr 131)
DOI
10.1200/jco.2015.33.28_suppl.131
Abstract #
131
Poster Bd #
G4
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Development of a risk calculator of recurrence in inguinal lymph node metastatic (ILNM) patients with surgically resected penile squamous cell carcinoma (PSCC).
First Author: Marco Bandini
Poster
2017 ASCO Annual Meeting
Clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions incorporated the 21-gene recurrence score (RS): Elderly (≥70 yrs) vs younger patients (Pts).
First Author: Salomon M. Stemmer
Poster
2022 ASCO Annual Meeting
Clinical implications for patients with discordant oncotype and MammaPrint results.
First Author: Matei P. Socoteanu
Poster
2021 ASCO Quality Care Symposium
Characterizing attitudes related to child-bearing in young women diagnosed with early breast cancer (EBC).
First Author: Saumya Umashankar